Royal DSM NV (DSM):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7164)
◆英語タイトル:Royal DSM NV (DSM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7164
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:オランダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop residues and bio-chemicals. The company serves customers in animal nutrition and health, packaging and graphic arts, building and construction, pharma solutions, electrical and electronics, automotive, medical, personal care, energy, food, furniture, life protection, beverages and dietary supplements, marine, paint and coatings, manufacturing and equipment, sports, leisure and consumer goods, and textiles and clothing sectors. The company has operations across Eastern Europe, Latin America, North America, Asia, and other regions. DSM is headquartered in Heerlen, the Netherlands.

Royal DSM NV (DSM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Royal DSM NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Royal DSM NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Royal DSM NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Royal DSM NV, Medical Equipment, Deal Details 10
Venture Financing 10
MIACH Orthopaedics Raises USD22.5 Million in Series A Venture Financing 10
Bio2 Technologies Raises USD4.5 Million in Series C Financing 11
Essential Medical Raises USD15 Million in Series B Financing 12
Interface Biologics Raises Funds Through Extended Series B Venture Financing 13
Regentis Biomaterials Raises US$10 Million In Series C Financing 14
Partnerships 15
DSM Enters Into Licensing Agreement With SpineVision For Bionate II PCU 15
Royal DSM Extends Licensing Agreement With AxioMed Spine For CarboSil TSPCU 16
Vention Medical Enters into Agreement with Royal DSM 17
Royal DSM Enters into Distribution Agreement with Sebbin 18
DSM Enters Into Agreement With Sayan Orthopaedics For Dyneema Purity Fiber 19
Debt Offering 20
Royal DSM Completes Public Offering Of Bonds Due 2024 For US$684 Million 20
Royal DSM Completes Private Placement Of Bonds Due 2019 For US$405 Million 21
Acquisition 22
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 22
Royal DSM NV – Key Competitors 24
Royal DSM NV – Key Employees 25
Royal DSM NV – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 29
Recent Developments 31
Strategy And Business Planning 31
Apr 03, 2017: Royal DSM Opens New Biotechnology Center in Delft, the Netherlands 31
Financial Announcements 32
Aug 01, 2018: DSM announces H1 2018 results 32
May 08, 2018: DSM Reports Q1 2018 Results 33
Feb 15, 2018: DSM Reports 2017 Results 34
May 02, 2017: DSM Q1 2017 Results 41
Feb 15, 2017: DSM reports 2016 results 42
Feb 14, 2017: DSM new presentation of accounts as from Q4 2016 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Royal DSM NV, Medical Equipment, Key Facts, 2017 2
Royal DSM NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Royal DSM NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Royal DSM NV, Deals By Market, 2012 to YTD 2018 8
Royal DSM NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MIACH Orthopaedics Raises USD22.5 Million in Series A Venture Financing 10
Bio2 Technologies Raises USD4.5 Million in Series C Financing 11
Essential Medical Raises USD15 Million in Series B Financing 12
Interface Biologics Raises Funds Through Extended Series B Venture Financing 13
Regentis Biomaterials Raises US$10 Million In Series C Financing 14
DSM Enters Into Licensing Agreement With SpineVision For Bionate II PCU 15
Royal DSM Extends Licensing Agreement With AxioMed Spine For CarboSil TSPCU 16
Vention Medical Enters into Agreement with Royal DSM 17
Royal DSM Enters into Distribution Agreement with Sebbin 18
DSM Enters Into Agreement With Sayan Orthopaedics For Dyneema Purity Fiber 19
Royal DSM Completes Public Offering Of Bonds Due 2024 For US$684 Million 20
Royal DSM Completes Private Placement Of Bonds Due 2019 For US$405 Million 21
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 22
Royal DSM NV, Key Competitors 24
Royal DSM NV, Key Employees 25
Royal DSM NV, Other Locations 26
Royal DSM NV, Subsidiaries 26
Royal DSM NV, Joint Venture 29

List of Figures
Royal DSM NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Royal DSM NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Royal DSM NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Royal DSM NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Royal DSM NV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Royal DSM NV (DSM):医療機器:M&Aディール及び事業提携情報(Royal DSM NV (DSM) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆